Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Adherence to bisphosphonates and hormone...
Journal article

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database

Abstract

Therapies for osteoporosis must be taken for at least 1 year to be effective. The purpose of this study was to determine the difference in adherence to etidronate, alendronate and hormone replacement therapy in a group of patients seen at our tertiary care centres. The Canadian Database of Osteoporosis and Osteopenia (CANDOO), a prospective observational database designed to capture clinical data, was searched for patients who started therapy …

Authors

Papaioannou A; Ioannidis G; Adachi JD; Sebaldt RJ; Ferko N; Puglia M; Brown J; Tenenhouse A; Olszynski WP; Boulos P

Journal

Osteoporosis International, Vol. 14, No. 10, pp. 808–813

Publisher

Springer Nature

Publication Date

10 2003

DOI

10.1007/s00198-003-1431-2

ISSN

0937-941X